-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EDQC6JInJioLmAgQcWK4PTwk8W5yh6FdG7vC8OYLk22qlnklNVii3K+Nn8xw/w7p zxZiUuqRyzueZy4cG55AxQ== /in/edgar/work/0000950130-00-006357/0000950130-00-006357.txt : 20001129 0000950130-00-006357.hdr.sgml : 20001129 ACCESSION NUMBER: 0000950130-00-006357 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20001113 ITEM INFORMATION: FILED AS OF DATE: 20001128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BECTON DICKINSON & CO CENTRAL INDEX KEY: 0000010795 STANDARD INDUSTRIAL CLASSIFICATION: [3841 ] IRS NUMBER: 220760120 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: SEC FILE NUMBER: 001-04802 FILM NUMBER: 778236 BUSINESS ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417-1880 BUSINESS PHONE: 2018476800 MAIL ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKE STATE: NJ ZIP: 07417 8-K/A 1 0001.txt AMENDMENT TO FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 13, 2000 ----------------- BECTON, DICKINSON AND COMPANY - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 - -------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer Iden- diction of incorporation) File Number) tification Number) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (201) 847-6800 -------------- N/A - -------------------------------------------------------------------------------- (Former name or former addresses if changed since last report.) Item 9. Regulation FD Disclosure See the supplemental financial information attached hereto as Exhibit 99, which is incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BECTON, DICKINSON AND COMPANY (Registrant) By: /s/ Michelle L. Defazio ----------------------- Michelle L. Defazio Assistant Secretary Date: November 14, 2000 - 2 - INDEX TO EXHIBITS ----------------- Exhibit Number Description of Exhibits ------ ----------------------- 99 Supplemental Financial Information EX-99 2 0002.txt SUPPLEMENTAL FINANCIAL INFORMATION BD FY 2000 Revenues by Business Segments and Major Product Groups ($ in Millions)
Quarter 4 Total Year ----------------------------- ------------------------------ Amount % Growth Amount % Growth ------ -------- ------ -------- Medical Injection Systems $ 153 -0.7% $ 609 5.8% Infusion Therapy Systems 79 -5.1% 342 2.1% Consumer Health Care 143 -10.7% 505 -1.5% Pharmaceutical Systems 66 13.6% 255 7.1% Other 61 -5.1% 255 -2.9% ------ ------ -------- ----- 502 -3.4% 1,966 2.2% Preanalytical Solutions 131 2.2% 535 5.1% Biosciences Flow Cytometry 113 35.1% 407 36.3% Microbiology 137 2.2% 568 2.7% Labware 37 0.5% 143 6.2% ------ ------ -------- ----- 287 12.7% 1,118 13.4% ------ ------ -------- ----- Total Company $ 920 1.9% $ 3,618 5.8% ====== ====== ======== =====
-----END PRIVACY-ENHANCED MESSAGE-----